References
- Annapurna A, Kumar VK, Rao PMM, Rao KS, Rajasekhar J (2002) Multiple sclerosis: the dis-ease and its treatment. Indian J Pharmacol; 34: 3–15
- Hafler D A (2004) Multiple sclerosis. J Clin Invest; 113: 788–794
- Cuzner ML, Davison AN (1973) Changes in cerebral lysosomal enzyme activity and lipids in multiple sclerosis. J Neurol Sci;19: 29–36
- McKeown ML, Allen IV (1979) The cellular origin of lysosomal enzymes in plaque in multiple sclerosis: a combined histological and biochemical study. Neuropathol Appl Neurobiol; 4: 471–482
- Halonen T, Kilpeldinen H, Pitkänen A, Riekkinen PJ (1987) Lysosomal hydrolases in cerebrospi-nal fluid of multiple sclerosis patients. A follow-up study. J Neurol Sci; 79: 267–274
- Hultberg B, Olsson JE (1978) Diagnostic value of determination of lysosomal hydrolases in CSF of patients with neurological diseases. Acta Neurol Scand; 57: 201–215
- Goi G, Caputo D, Bairati C et al (1993) Enzymes of lysosomal origin in the cerebrospinal fluid and plasma of patients with multiple sclerosis. Eur Neurol; 33: 1–4
- Hultberg B, Olsson JE (1979) Lysosomal hydrolases in CFS of patients with multiple sclerosis. Acta Neurol Scand; 59: 23–30
- Braidan I, Carol M, Robinson D (1974) Separation and properties of human brain hexosamini-dase C. Biochem J; 143: 295–301
- Datti A, Emiliani C, Capocchi G, Orlacchio A (1991) 13-N-Acetylhexosaminidase in human cer-ebrospinal fluid and serum of patients with mitltiple sclerosis. Chin Chim Acta; 200: 73–80
- Emiliani C, Capocchi G, Zampolini M, Orlacchio A (1995) Association between seric 13-hexosaminidase isoenzyme patterns and multiple sclerosis. Chin Chem Enzym Commun; 7: 1–7
- Perez LF, Tutor JC (1998) Assay of13-N-acetylhexosaminidase isoenzymes in different biological specimens by means of determination of their activation energies. Chin Chem; 44: 226–231
- Perez LF, Ribeiro HM, Casal JA, Pinto RA, Sá Miranda MC, Tutor JC (1999) Thermodynamic characterisation of the mutated isoenzyme A of 13-N-acetylhexosaminidase in GM2-gangliosi-doses B1 variant. Clin Chim Acta; 9: 285, 45–51
- Poser CM, Paty DW, Scheinberg L et al (1983) New disgnostic criteria for multiple sclerosis. Guidelines for research protocols. Arm Neurol; 13: 227–231
- Falip M, Tintoré M, Jardi R, Duran I, Link H, Montalban X (2001) Utilidad clinica de las bandas oligoclonales. Rev Neurol; 32: 1120–1124
- Thompson EJ, Keir G (1990) Laboratory investigation of cerebrospinal fluid proteins. Arm Clin Biochem; 27: 425–435
- Poser CM (1993) The pathogenesis of multiple sclerosis. Additional considerations. J Neurol Sci; 115 (Suppl.): S3–S15
- Kaiser E, Kuzmits R, Pregant P, Burghuber 0, Worofka W (1989) Clinical biochemistry of neu-ron specific enolase. Clin Chim Acta; 183: 13–32
- Royds JA, Davies-Jones GB, Lewtas NA, Timperley WR, Taylor CB (1983) Enolase isoenzymes in the cerebrospinal fluid of patients with diseases of nervous system. J Neurol Neurosurg Psy-chiatr; 46: 1031–1036
- Adams CW, Poston RN, Buk SJ (1989) Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis. J Neurol Sci; 183: 13–32
- Pampols T, Codina J, Girós M, Sabater J, Gonzalez-Sastre F (1980) Tissue diferences in the hu-man N-acetyl-13-D-glucosaminidase. Cell Molec Biol; 26: 187–195
- Saso L, Valentini G, Leone MG et al (1999) Changes in concanavalin A-reactive proteins in neu-rological disorders. J Clin Lab Anal; 13: 158–165
- Isaksson A, Hultberg B, Jonung T (1992) Rat plasma clearance rate and organ distribution of I3-hexosaminidase isoenzymes from human serum. Clin Chem; 38: 1893–1898
- Isaksson A, Hultberg B (1995) Serum 13-hexosaminidase isoenzymes are precursor forms. Scand J Clin Lab Invest; 55: 433–440
- Casal JA, Cano E, Tutor JC (2005) 13-Hexosaminidase isoenzyme profiles in serum, plasma, platelets and mononuclear, polymorphonuclear and unfractionated total leukocytes. Clin Bio-chem; 38: 938–942